Annual EBITDA
-$89.44 M
-$29.59 M-49.44%
December 31, 2022
Summary
- As of February 10, 2025, GRCL annual EBITDA is -$89.44 million, with the most recent change of -$29.59 million (-49.44%) on December 31, 2022.
- During the last 3 years, GRCL annual EBITDA has fallen by -$70.10 million (-362.61%).
Performance
GRCL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$9.16 M
+$11.56 M+55.77%
September 30, 2023
Summary
- As of February 10, 2025, GRCL quarterly EBITDA is -$9.16 million, with the most recent change of +$11.56 million (+55.77%) on September 30, 2023.
- Over the past year, GRCL quarterly EBITDA has increased by +$11.56 million (+55.77%).
Performance
GRCL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$69.93 M
+$15.66 M+18.30%
September 30, 2023
Summary
- As of February 10, 2025, GRCL TTM EBITDA is -$69.93 million, with the most recent change of +$15.66 million (+18.30%) on September 30, 2023.
- Over the past year, GRCL TTM EBITDA has increased by +$15.66 million (+18.30%).
Performance
GRCL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GRCL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.4% | +55.8% | +18.3% |
| 3 y3 years | -362.6% | +55.8% | +18.3% |
| 5 y5 years | -922.9% | +55.8% | +18.3% |
GRCL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +49.4% | at low | at high | +170.9% | +1.0% | +30.6% |
| 5 y | 5-year | +362.6% | at low | +101.5% | +170.9% | +1087.5% | +30.6% |
| alltime | all time | +922.9% | at low | +101.5% | +170.9% | +1087.5% | +30.6% |
Gracell Biotechnologies EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$9.16 M(-55.8%) | -$69.93 M(-18.3%) |
| Jun 2023 | - | -$20.72 M(-5.5%) | -$85.59 M(-1.3%) |
| Mar 2023 | - | -$21.92 M(+21.0%) | -$86.75 M(-3.1%) |
| Dec 2022 | -$89.44 M(+49.4%) | -$18.12 M(-27.0%) | -$89.55 M(-1.9%) |
| Sep 2022 | - | -$24.83 M(+13.5%) | -$91.32 M(+5.8%) |
| Jun 2022 | - | -$21.88 M(-11.5%) | -$86.29 M(+9.1%) |
| Mar 2022 | - | -$24.72 M(+24.3%) | -$79.08 M(+14.2%) |
| Dec 2021 | -$59.85 M | -$19.89 M(+0.5%) | -$69.22 M(+14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$19.80 M(+34.9%) | -$60.41 M(+26.3%) |
| Jun 2021 | - | -$14.67 M(-1.3%) | -$47.82 M(+21.0%) |
| Mar 2021 | - | -$14.86 M(+34.2%) | -$39.53 M(+35.3%) |
| Dec 2020 | -$27.26 M(+41.0%) | -$11.08 M(+53.6%) | -$29.22 M(+21.6%) |
| Sep 2020 | - | -$7.21 M(+12.9%) | -$24.03 M(+42.8%) |
| Jun 2020 | - | -$6.39 M(+40.5%) | -$16.82 M(+61.2%) |
| Mar 2020 | - | -$4.55 M(-22.8%) | -$10.44 M(+77.2%) |
| Dec 2019 | -$19.33 M(+121.1%) | -$5.89 M | -$5.89 M |
| Dec 2018 | -$8.74 M | - | - |
FAQ
- What is Gracell Biotechnologies annual EBITDA?
- What is the all time high annual EBITDA for Gracell Biotechnologies?
- What is Gracell Biotechnologies annual EBITDA year-on-year change?
- What is Gracell Biotechnologies quarterly EBITDA?
- What is the all time high quarterly EBITDA for Gracell Biotechnologies?
- What is Gracell Biotechnologies quarterly EBITDA year-on-year change?
- What is Gracell Biotechnologies TTM EBITDA?
- What is the all time high TTM EBITDA for Gracell Biotechnologies?
- What is Gracell Biotechnologies TTM EBITDA year-on-year change?
What is Gracell Biotechnologies annual EBITDA?
The current annual EBITDA of GRCL is -$89.44 M
What is the all time high annual EBITDA for Gracell Biotechnologies?
Gracell Biotechnologies all-time high annual EBITDA is -$8.74 M
What is Gracell Biotechnologies annual EBITDA year-on-year change?
Over the past year, GRCL annual EBITDA has changed by -$29.59 M (-49.44%)
What is Gracell Biotechnologies quarterly EBITDA?
The current quarterly EBITDA of GRCL is -$9.16 M
What is the all time high quarterly EBITDA for Gracell Biotechnologies?
Gracell Biotechnologies all-time high quarterly EBITDA is -$4.55 M
What is Gracell Biotechnologies quarterly EBITDA year-on-year change?
Over the past year, GRCL quarterly EBITDA has changed by +$11.56 M (+55.77%)
What is Gracell Biotechnologies TTM EBITDA?
The current TTM EBITDA of GRCL is -$69.93 M
What is the all time high TTM EBITDA for Gracell Biotechnologies?
Gracell Biotechnologies all-time high TTM EBITDA is -$5.89 M
What is Gracell Biotechnologies TTM EBITDA year-on-year change?
Over the past year, GRCL TTM EBITDA has changed by +$15.66 M (+18.30%)